Nivolumab produces durable responses & long-term survival in severe liver cancer patients - @EASLnews #ILC2017 https://t.co/lYR9ruMe1Z
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://twitter.com/ecancer/status/855363087972610048
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου